Summary
Image AddedThis collection contains data from the National Cancer Insitute Clinical Trial NCT00533949, "High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery." It was sponsored by NCI's Radiation Therapy Oncology Group (RTOG) under study number RTOG-0617. Clinical data which will allow users to compare the adverse events and treatments between arms in trial are located on the NCTN/NCORP Data Archive. Each patient's CT of the chest (including the adrenals) was obtained within 6 weeks of registration.
Trial Description
Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as paclitaxel, carboplatin work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as cetuximab can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. It is not yet known whether high-dose radiation therapy is more effective than standard-dose radiation therapy when given together with combination chemotherapy with or without cetuximab in treating patients with non-small cell lung cancer. This randomized phase III trial is studying high-dose or standard-dose radiation therapy given together with chemotherapy with or without cetuximab to see how well they work in treating patients with newly diagnosed stage III non-small cell lung cancer that cannot be removed by surgery.
Trial Outcomes
Results of the trial have been reported in the following publications:
Movsas B, Hu C, Sloan J, Bradley J, Komaki R, Masters G, Kavadi V, Narayan S, Michalski J, Johnson DW, Koprowski C, Curran WJ Jr, Garces YI, Gaur R, Wynn RB, Schallenkamp J, Gelblum DY, MacRae RM, Paulus R, Choy H. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. JAMA Oncol. 2016 Mar;2(3):359-67. doi: 10.1001/jamaoncol.2015.3969. (linkPMC4786463)
Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W Jr, Choy H. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015 Feb;16(2):187-99. doi: 10.1016/S1470-2045(14)71207-0. Epub 2015 Jan 16. (linkPMC4419359)
Localtab Group |
---|
Localtab |
---|
active | true |
---|
title | Data Access |
---|
| Data AccessThis is a limited access data set. To request access please register an account on the NCTN Data Archive and . After logging in, use the "Request Data" link in the left side menu. Follow the on screen instructions, and enter enter NCT00533949 when asked which trial you want to request. In In step 2 of the Create Request form, be sure to select “Imaging Data Requested”. Please contact NCINCTNDataArchive@mail.nih.gov for any questions about access requests.Once access is granted, click the Download button to save a ".tcia" manifest file to your computer, which you must open with the NBIA Data Retriever. Click the Search button to open our Data Portal, where you can browse the data collection and/or download a subset of its contents. Data Type | Download all or Query/Filter |
---|
Images | License |
---|
Images and Radiation Therapy Structures ( 42.7GB) |
| Clinical Data on NCTN Data Archive |
Tcia button generator |
---|
url | https://wiki.cancerimagingarchive.net/download/attachments/33948334/NSCLC-Cetuximab-NBIA-manifest-1542748233353.tcia?version=1&modificationDate=1542748333870&api=v2 |
---|
|
|
Tcia button generator |
---|
label | Search |
---|
url | https://nbia.cancerimagingarchive.net/nbia-search/?MinNumberOfStudiesCriteria=1&CollectionCriteria=NSCLC-Cetuximab |
---|
|
|
(Download requires the NBIA Data Retriever)
| Nctn_with_collab license only |
---|
| Image RemovedClick the Versions tab for more info about data releases. Additional Resources for this Dataset |
Localtab |
---|
title | Detailed Description |
---|
| Detailed Description | |
---|
Modalities | CT, RTSTRUCT, RTDOSE, RTPLAN | Number of PatientsParticipants | 490 | Number of Studies | 490 | Number of Series | 2116 | Number of Images | 75063 | Image Size (GB) | 42.7 |
Include Page |
---|
| National Clinical Trials Network (NCTN) Date Handling |
---|
| National Clinical Trials Network (NCTN) Date Handling |
---|
|
|
Localtab |
---|
title | Citations & Data Usage Policy |
---|
| Citations & Data Usage Policy This is a limited access data set. Upon receiving access you may only use it for the purposes outlined in your request to the data provider. You are not allowed to redistribute the data or use it for other purposes. See TCIA's Data Usage Policies and Restrictions for additional details. Questions may be directed to help@cancerimagingarchive.net. Please be sure to include the following citations in your work if you use this data set: Tcia limited license policy |
---|
Info |
---|
| Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, Moore S, Phillips S, Maffitt D, Pringle M, Tarbox L, Prior F. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository, Journal of Digital Imaging, Volume 26, Number 6, December, 2013, pp 1045-1057. DOI: https://doi.org/10.1007/s10278-013-9622-7 |
Additional Publication Resources:The Collection authors suggest the below will give context to this dataset: Movsas B, Hu C, Sloan J, Bradley J, Komaki R, Masters G, Kavadi V, Narayan S, Michalski J, Johnson DW, Koprowski C, Curran WJ Jr, Garces YI, Gaur R, Wynn RB, Schallenkamp J, Gelblum DY, MacRae RM, Paulus R, Choy H. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. JAMA Oncol. 2016 Mar;2(3):359-67. doi: 10.1001/jamaoncol.2015.3969. (PMC4786463) Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W Jr, Choy H. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015 Feb;16(2):187-99. doi: 10.1016/S1470-2045(14)71207-0. Epub 2015 Jan 16. (PMC4419359)
Other Publications Using This DataSee the TCIA Publications page for other work leveraging this collection. If you have a publication you'd like to add please contact the TCIA Helpdesk. |
Localtab |
---|
| Version 1 (Current): Updated 2019/04/15Data Type | Download all or Query/Filter |
---|
Images ( 42.7GB) |
| Clinical Data on NCTN Data Archive | |
Tcia button generator |
---|
url | https://wiki.cancerimagingarchive.net/download/attachments/33948334/NSCLC-Cetuximab-NBIA-manifest-1542748233353.tcia?version=1&modificationDate=1542748333870&api=v2 |
---|
|
|
Tcia button generator |
---|
label | Search |
---|
url | https://nbia.cancerimagingarchive.net/nbia-search/?MinNumberOfStudiesCriteria=1&CollectionCriteria=NSCLC-Cetuximab |
---|
|
|
(Download requires the NBIA Data Retriever) | Image Removed
|
|